Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-α blocking agents

Annals of the Rheumatic Diseases

Volumn 68, Issue 2, 2009, Pages 249-252

  Halvorsen, E H ^a,e   Haavardsholm, E A ^b   Pollmann, S ^a   Boonen, A ^c   Van Der Heijde, D ^b,d   Kvien, T K ^b   Molberg, O ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b DIAKONHJEMMET HOSPITAL   (Norway)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; IMMUNOGLOBULIN G; INFLIXIMAB; PROTEIN ARGININE DEIMINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RADIOGRAPHY; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROLASES; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58849138389     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.094490     Document Type: Article

References (15)

1. Scott DL, Kingsley GH. Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med 2006;355:704-12.
2. IQevit W, Fransen J, Oerlemans AJ, Kuper HH, van der Laar MA, De Rooij DJ, et al. The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice. Ann Rheum Dis 2007;66:1473-8.
3. Padyukov L, Lampa J, Heimburger M, Ernestam S, Cederholm T, Lundkvist I, et al. Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis. Ann Rheum Dis 2003;62:526-9.
4. Hyrich KL, Watson KD, Silman AJ, Symmons DP. Predictors of response to anti-TNF- alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologies Register. Rheumatology 2006;45:1558-65.
5. Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, Falappone PC, Ferrante A, Malesci D, et al. Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. J Rheumatol 2007;34:1670-3.
6. Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde 0, et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum 2005;52:1020-30.
7. Halvorsen EH, Pollmann S, Gilboe IM, van der Heijde D, Landewé R, Odegaard S, et al. Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity. Ann Rheum Dis 2008;67:414-17.
8. Takizawa Y, Sawada T, Suzuki A. Yamada R, Inoue T, Yamamoto K. Peptidylarginme deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis. Scand J Rheumatol 2005;34:212-15.
9. Zhao J, Zhao Y, He J, Jia R, Li Z. Prevalence and significance of anti-peptidylargmine deiminase 4 antibodies in rheumatoid arthritis. J Rheumatol Epub 2008;35:969-74
10. Foulquier C, Sebbag M, Clavel C, Chapuy-Regaud S, Al Badine R, Méchin MC, et al Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum 2007;56:3541-53.
11. Haavardsholm EA, Boyesen P. ostergaard M, Schildvold A. Kvien TK MRI findings in 84 early rheumatoid arthritis patients: bone marrow oedema predicts erosive progression. Ann Rheum Dis 2008, 67:794-800.
12. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999;26:743-5.
13. Mastronardi FG, Wood DD, Mei J, Raijmakers R, Tseveleki V, Dosch HM, e al. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J Neurosci 2006;26:11387-96.
14. Kjraly R, Vecsei Z, Demenyi T, Korponay-Szabo IR, Fesus L. Coeliac autoantibodies can enhance transamidating and inhibit GTPase activity of tissue transglutaminase dependence on reaction environment and enzyme fitness J Autoimmun 2006;26:278-87.
15. van den Berg WB, van Lent PL, Joosten LA, Abdollahi-Roodsaz S, Koenders Ml Amplifying elements of arthritis and joint destruction Ann Rheum Dis 2007;66(Suppl 3):iii45-8.